NCT01400477View on ClinicalTrials.gov

Nicotinic Receptors and Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
SchizophreniaSchizoaffective Disorder
Interventions
DRUG

DMXB-A-SR

Experimental Study Drug: 3-2, 4 dimethoxybenzylidene anabaseine sustained release (DMXB-A-SR)

OTHER

Placebo

Placebo Comparator

Trial Locations (2)

80045

UColorado Denver, Aurora

University of Colorado-Anschutz Medical Campus, Department of Psychiatry, Aurora

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Colorado, Denver

OTHER

NCT01400477 - Nicotinic Receptors and Schizophrenia | Biotech Hunter | Biotech Hunter